Showing results (111-120 of 217) with videos related to
Sort By:
Pageof 22
NPJ Precision Oncology|December 18, 2021
High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibitionYing Ni, Ahmed Soliman, Amy Joehlin-Price, et al.Gynecologic Oncology|July 21, 2004
Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancerRachel A Dubay, Peter G Rose, David M O'Malley, et al.Gynecologic Oncology|August 26, 2014
Locally advanced adenocarcinoma and adenosquamous carcinomas of the cervix compared to squamous cell carcinomas of the cervix in gynecologic oncology group trials of cisplatin-based chemoradiationPeter G Rose, James J Java, Charles W Whitney, et al.Journal of Gynecologic Oncology|January 23, 2026
Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancerLaura M Chambers, Julia Chalif, Meng Yao, et al.Gynecologic Oncology|July 26, 2005
Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group studyBenjamin E Greer, Brian N Bundy, Robert F Ozols, et al.Gynecologic Oncology|May 23, 2006
Phase II study of oxaliplatin as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group studyPaula M Fracasso, John A Blessing, Kelly L Molpus, et al.Gynecologic Oncology|February 15, 2003
A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a Gynecologic Oncology Group studyPeter G Rose, John A Blessing, Harrison G Ball, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2007
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group StudyPeter G Rose, Shamshad Ali, Edwin Watkins, et al.Anti-Cancer Drugs|July 23, 2020
Incidence of squamous cell carcinomas of the head and neck following prolonged pegylated liposomal doxorubicinPeter G Rose, Frances Fu, Laura M Chambers, et al.Diabetes Technology & Therapeutics|August 25, 2020
Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 DiabetesLaura M Jacobsen, Brian N Bundy, Madison N Greco, et al.Pageof 22